The management of large spontaneous portosystemic shunt (SPSS) during liver transplantation (LT) is a matter of debate. The aim of this study is to compare the short-term and longterm outcomes of SPSS ligation versus nonligation during LT, when both options are available. From 2011 to 2017, 66 patients with SPSS underwent LT: 56 without and 10 with portal vein thrombosis (PVT), all of whom underwent successful thrombectomy and could have portoportal reconstruction. The SPSS were either splenorenal (n 5 40; 60.6%), left gastric (n 5 16; 24.2%), or mesenterico-iliac (n 5 10; 15.1%). Following portoportal anastomosis, the SPSS was ligated in 36 (54.4%) patients and left in place in 30 (45.5%) patients, based on the effect of the SPSS clamping/unclamping test on portal vein flow during the anhepatic phase. Intraoperatively, satisfactory portal flow was obtained in both groups. Primary nonfunction (PNF) and primary dysfunction (PDF) rates did not differ significantly between the 2 groups. Nonligation of SPSS was significantly associated with a higher rate of postoperative encephalopathy (P < 0.001) and major postoperative morbidity (P 5 0.02). PVT occurred in 0 and 3 patients in the ligated and nonligated shunt group, respectively (P 5 0.08). A composite end point, which included the relevant complications in the setting of SPSS in LT (ie, PNF and PDF, PVT, and encephalopathy) was present in 16 (44.4%) and 22 (73.3%) patients of the ligated and nonligated shunt group, respectively (P 5 0.02). Patient (P 5 0.05) and graft (P 5 0.02) survival rates were better in the ligated shunt group. In conclusion, the present study supports routine ligation of large SPSS during LT whenever feasible.
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Received September 10, 2017; accepted December 3, 2017. Large spontaneous portosystemic shunts (SPSSs; > 1 cm), when left in place at liver transplantation (LT), have been associated with an increased risk of primary nonfunction (PNF) and primary dysfunction (PDF), portal vein thrombosis (PVT), or encephalopathy possibly due to the so-called portal flow steal phenomenon and the subsequent decreased portal inflow to the graft. (1) (2) (3) To prevent these complications, some have advocated ligation of large SPSSs following graft revascularization.
The majority of authors describe successful shortterm outcomes after ligation of SPSSs. (4) (5) (6) (7) (8) (9) However, longterm outcomes are rarely reported. In addition, access to, and ligation of SPSS may be technically challenging and associated with massive bleeding in the setting of severe portal hypertension in a patient with cirrhosis (10) and could sometimes also lead to inferior vena cava (IVC) thrombosis. (11) On the other hand, the outcomes of preservation of SPSSs following graft reperfusion have been poorly explored. (3, 12) A large series of consecutive cases of SPSSs managed according to a prospective management algorithm is analyzed here to assess whether SPSS ligation or not achieves similar short-term and longterm outcomes when both options to ligate the shunt or not are available.
Patients and Methods

STUDY POPULATION AND DESIGN
After approval of the present study by the institutional review board, data from 429 consecutive patients who underwent LT at Henri Mondor University Hospital (Cr eteil, France) from January 2011 to January 2017 were retrospectively reviewed from the prospectively maintained database (as per the guidelines of the French National Agency for Organ Sharing and Transplantation).
Large SPSS was defined as the presence of SPSS > 1 cm in diameter (splenorenal, left gastric, or mesenterico-iliac) on pretransplant imaging, ie, computed tomography (CT) scan and/or magnetic resonance imaging. (5, 13) PVT, whenever present, was graded according to Yerdel's classification. (14) Patients with partial PVT and SPSS were evaluated with Doppler ultrasonography (DUS) whether portal flow was hepatofugal (ie, reversed) or hepatopetal. In this study, none of the patients with SPSS identified preoperatively underwent pretransplantation embolization of the SPSS.
For this study, only those patients in whom thrombectomy with recanalization, with use of portoportal anastomoses during LT were retained. Stage 4 PVT patients were excluded, as in these cases, portal reconstruction by anastomosing the shunt (in case of large gastric vein) or its drainage vein (ie, the left renal vein in case of splenorenal shunt) to the graft portal vein was necessary.
Finally, the study population included all consecutive patients with SPSS provided both options of portoportal reconstruction with or without SPSS ligation were available. The study population with SPSS was divided into 2 groups: ligated shunt group and nonligated shunt group.
SURGICAL STRATEGY
The surgical strategy for patients with SPSS was prospectively decided at a weekly LT board meeting and recorded in the patient's charts. The transplant surgeon reviewed the latter just before surgery. The surgical 3-step strategy was as follows.
First
Step: Control of the SPSS After Total Hepatectomy Total hepatectomy preserving the IVC (whenever feasible) was performed. Venovenous bypass was used selectively in case of IVC resection according to the previously reported criteria. (15) The SPSS was then controlled and taped during the anhepatic phase to allow its rapid stapling when the decision for the same was made. SPSS were left open during the anhepatic phase to minimize splanchnic congestion. Portal vein thrombectomy in case of stage 1-3 PVT was performed as previously described. (16) The arterial anastomosis site was prepared to prevent prolonged warm ischemia.
Second
Step: Clamping Test of the SPSS During the Anhepatic Phase
In the anhepatic phase, the portal vein clamp was briefly released in the operating field, before and after SPSS clamping to see if there was an increase in the portal vein flow after SPSS clamping. If the flow was better after SPSS clamping, the SPSS was rapidly ligated after revascularization of the graft. In case of spontaneous splenorenal shunt, the left renal vein, controlled on the left border of the IVC, was used for this test of SPSS clamping. In other patients, the SPSS was controlled directly. Past history of encephalopathy, defined as at least 1 episode of spontaneous encephalopathy, the presence of encephalopathy at the time of transplantation, and the presence of a hepatofugal flow in the portal vein diagnosed preoperatively, were not prospectively considered as formal indications to ligate the shunt.
Third
Step: Graft Implantation and Definitive Management of SPSS Graft implantation started with caval reconstruction. Portal reconstruction was performed using portoportal anastomosis following portal thrombectomy when indicated. Stapling of the SPSS (or the left renal vein in case of spontaneous splenorenal shunt) was performed rapidly after graft revascularization, when this was indicated by the shunt clamping test.
Arterial and biliary reconstructions were performed as usual. Intraoperative DUS control and routine graft biopsy to evaluate the degree of macrovesicular steatosis and ischemia/reperfusion injury, if any, were performed before abdomen closure. (17) 
POSTOPERATIVE MANAGEMENT
The standard postoperative protocol for LT recipients was followed. (18, 19) DUS was performed on postoperative days (PODs) 1, 3, and 6 and once a week until discharge from the hospital to assess the arterial patency and resistive index, and portal flow and venous outflow dynamics. Portal flow was not quantified but analyzed on a quality standpoint by the same radiologist.
Routine CT angiography was performed between POD 7 and POD 10. Additional CT was performed in the event of DUS abnormalities and/or unexplained rebound of transaminases levels.
DEFINITION OF OUTCOMES
Perioperative mortality and morbidity, graded according to Clavien-Dindo classification, (20) were defined as death or complication occurring within 90 days after LT or during the same hospitalization. In case of multiple complications, the highest grade was retained for analysis. Furthermore, postoperative complications were divided into 2 groups: liver-related and general complications.
Liver-related complications included biliary and vascular (portal vein, arterial, hepatic, and venous outflow related) complications, hemorrhage needing reoperation or transfusion >2 red blood cell units, and intra-abdominal infection. Post-LT encephalopathy was noted as absent or present. PNF and PDF were diagnosed according to the acknowledged criteria. (21, 22) General complications included cardiovascular, pulmonary, cerebrovascular, acute kidney injury, (23) systemic infections, and rejection.
DATA ANALYSIS
All quantitative data are expressed as mean 6 standard deviation. The Mann-Whitney U test or paired t test for continuous variables and the v 2 or Fisher's exact test for categorical variables were used as indicated. Survival rates were calculated using the Kaplan-Meier method, and groups were compared using the log-rank test. Survival was measured from the time of LT to the last follow-up or the date of death from any cause.
Statistical analyses were performed using SPSS, version 20.0 (SPSS Inc., Chicago, IL). A P value < 0.05 was considered statistically significant.
For encephalopathy, a linear mixed-effect logistic regression model was used, using random effects, introducing the patient as a random factor.
To increase statistical power, a composite end point was used as a single dichotomous outcome. This composite end point combined the complications recognized as relevant in the setting of SPSS in LT, ie, PNF, PDF, PVT, and encephalopathy. (24, 25) The composite end point was considered as present when at least 1 of its components was fulfilled. The present study complies with the Reporting of Studies Conducted Using Observational Routinely-collected Health Data (RECORD) guidelines.
Results
PATIENT CHARACTERISTICS
During the study period, 429 consecutive LTs were performed. No SPSS was identified in 354 patients including 24 with PVT. In the 24 latter patients, PVT was graded from 1 to 3, and this could be desobstructed allowing portoportal anastomosis in all patients.
During the same period, 75 LTs were performed in patients with SPSS including 56 (74.7%) without and 19 (25.3%) with PVT (grade 1-3 in 10 patients and grade 4 in 9 patients).
After exclusion of the 9 latter patients (grade 4 PVT) as already explained, the study population comprised the remaining 66 patients.
In the study population, the SPSS was splenorenal in 40 (60.6%) patients, left gastric in 16 (24.2%) patients, and mesenterico-iliac in 10 (15.1%) patients.
As shown in Table 1 , the 2 groups were not different for the relevant donor and recipient characteristics.
OPERATIVE CHARACTERISTICS
According to shunt clamping test, SPSS was ligated in 36 (54.5%) patients (ligated shunt group) and not in 30 (45.5%) patients (nonligated shunt group). Intraoperatively, satisfactory portal flow was obtained in both groups. Figure 1 summarizes the study population, the portal flow reconstruction, and the management of the SPSS.
The 2 groups were not different for all relevant intraoperative events except cold ischemia time. The latter was significantly longer in the nonligated shunt group (P 5 0.01; Table 2 ).
POSTOPERATIVE MORTALITY
There were 2 postoperative deaths (3%). Both deaths occurred in the nonligated shunt group (mortality rate 56.6% versus 0% in the ligated shunt group; P 5 0.20). The first patient died on POD 1 due to overwhelming multiorgan failure in the context of PNF, and the second patient died on POD 11 due to massive hemoperitoneum from rupture of a splenic artery aneurysm.
POSTOPERATIVE MORBIDITY
The incidence of PNF and PDF did not differ significantly between the 2 groups (P > 0.99 and P 5 0.13 for both comparisons, respectively; Table 3 ). Relevant postoperative liver and kidney function tests were similar between the 2 groups (Supporting Fig. 1 shows the course of these tests). Postoperative PVT occurred in 4.5% of patients (3/66): 0 in the ligated and 3 (10%) in the nonligated shunt group (P 5 0.08) including 1 with pretransplantation PVT. One patient required a reoperation due to total PVT on POD 1. A successful thrombectomy and ligation of a large splenorenal shunt was performed. This patient is alive and well 3 years after surgery. Systemic heparin anticoagulation regimen in the 2 remaining patients achieved full recanalization of partial PVT. Nonligation of SPSS was significantly associated with a higher rate of postoperative encephalopathy (P < 0.001).
The composite criterion was found present in 16 (44.4%) patients of the ligated shunt group and 22 (73.3%) patients of the nonligated shunt group (P 5 0.02).
Overall, 59 patients experienced at least 1 complication (morbidity rate 5 89%). Clavien grade III-IV complications occurred in 8 patients (22%) of the ligated shunt group and in 15 patients (50%) of the nonligated shunt group (P 5 0.02).
Early retransplantation (3 months) was needed at POD 3 in 1 patient in the ligated shunt group due to PNF (already cited). This patient is currently alive and well 3 years later.
In the subset of patients with splenorenal shunt, postoperative renal function assessed by serum creatinine level was not different, whether the left renal vein was ligated (21 patients) or not (19 patients; P 5 0.33; paired t test).
None of the patients developed posttransplant esophagogastric variceal hemorrhage.
For the study population, duration of intensive care unit (ICU; counting stay in ICU and step-down unit) and total hospitalization stay was 26.2 6 32.6 days and 49.1 6 39.4 days, respectively. These durations were not different between the 2 groups (Table 3) .
LONGTERM OUTCOMES
The overall mean follow-up was 25.1 6 15.6 months. At last follow-up, all surviving patients had patent portal vein on DUS. In the subset of patients with ligation of the left renal vein or of a mesenterico-iliac shunt, none developed thrombosis of the IVC. One patient from the SPSS preservation group had persistent encephalopathy 6 months after LT.
FIG. 1. Management of SPSS during deceased donor LT.
Overall, patient and graft survival rates at 1, 2, and 4 years were 94%, 94%, and 87%, and 89%, 83%, and 78%, respectively.
Graft survival at 1, 2, and 4 years in the ligated shunt group was 97%, 92%, and 92%, respectively; and 83%, 83%, and 63% in the nonligated shunt group, respectively (P 5 0.03; Fig. 2) .
Patient survival at 1, 2, and 4 years in the ligated shunt group was 97%, 92%, and 92%, respectively; and 83%, 83%, and 68% in the nonligated shunt group, respectively (P 5 0.05; Fig. 3 ).
Late retransplantation (>3 months) was needed in 3 patients: 2 in the ligated shunt group and 1 in the nonligated shunt group. In the ligated shunt group, both retransplantations were performed for hepatic arterial thrombosis: the first one had a retransplantation on POD 92 and the second 27 months after primary LT. In the nonligated shunt group, 1 patient was retransplanted due to ischemic cholangitis 3 months after primary LT. Thus, retransplantation was needed in 3 (8.3%) patients in the ligated shunt group and 1 (3.3%) in the nonligated shunt group (P 5 0.62).
Discussion
This present study supports ligation of large SPSSs using the clamp/unclamp test (with the portal vein unclamped in the operating field) as a guide while performing LT because it is associated with lower postoperative morbidity, a decreased rate of encephalopathy, and a trend toward a lower rate of PVT, compared with the nonligated shunt group. In the long term also, patient and graft survival rates were better in the ligated shunt group. Both groups received grafts of similar quality, the graft-to-body weight ratio was sufficient and comparable in both groups, and more importantly, both groups had satisfactory portal venous flow on the portal vein clamping test performed during the anhepatic phase.
Some studies have proposed that preservation of the SPSSs during LT could be detrimental due to the "portal flow steal phenomenon" decreasing the graft perfusion, and portal vein flow/pressure (1) (2) (3) with the subsequent risks of liver failure/dysfunction, PVT, and encephalopathy.
Although the present study did not confirm the risk on early graft function, there was a significantly higher risk of encephalopathy and a trend toward more post-LT PVT in the nonligated shunt group. This is in line with some previous reports.
( [1] [2] [3] One can postulate that, if the incidence of complications known to exacerbate portal hypertension, such as outflow block or rejection, had occurred in our series, the latter risk of post-LT PVT could have reached statistical significance (Table 3) . Furthermore, SPSS preservation was associated with a significantly higher incidence of major complications (Table 3) .
The prevalence of SPSSs (18%) and PVT (10%) in our series is similar to most previously published series NOTE: Data are given as n (%) or mean 6 standard deviation. *Classified as moderate to severe (versus absent) when at least 10% of hepatocytes were necrotic mainly in the center of the lobule or disseminated throughout. (17) of end-stage liver disease patients undergoing LT: 20%-40% for SPSSs (1, 9, 18, (26) (27) (28) and 5%-17% for PVT. (29) Notably, the prevalence of the combination of SPSS and PVT (4.4% [19 patients] , respectively, in the present series, Fig. 1) has not yet been reported.
Control and ligation of SPSSs can be technically challenging and may cause massive bleeding (10) due to the tortuous, fragile wall and generally deep location in the retroperitoneum of the SPSSs. Thus far, ligation of the left renal vein has been straightforward in our experience. Compared with other reports, (30) left renal vein ligation was not associated with impairment of renal function in our experience. To obviate the ligation of the left renal vein and this subsequent potential complication, the direct ligation of the cranial end of the splenorenal shunt has also been reported. (7, 31) We agree with others (31) that gastro-esophageal shunts are the most technically challenging SPSS to control. In addition to the above reasons for difficult SPSS control, gastro-esophageal shunts may be multiple in numbers and can contain previous embolization material. Stapling at the base of the left gastric ligament, including the left gastric artery, has been proposed to facilitate the maneuver of shunt ligation (10) in such instances.
We had worse results in the nonligated shunt group (higher incidence of encephalopathy, PVT, higher morbidity) despite a satisfactory portal vein clamping test in this group, ie, good flow in the portal vein even with the shunts unclamped during the anhepatic phase. This probably underlines the subjectivity of the SPSS clamping test, and the fact that the reliability of this test does not increase with experience (500 to > 1500 LTs experience for each of the senior surgeons in the present series).
In this study, overall patient and graft survival in patients with SPSS are also in accordance with existing large series. (32) The hypothesis behind the longterm improvement in outcomes may be related to the potential benefits, particularly in relation to the improvement of hepatic encephalopathy and portal vein patency. Lengths of stay were long in the present series as compared with the literature because of the following:
1. ICU stay and step-down stay are counted together in our data file. 2. A large proportion of our patients remain hospitalized until they are deemed to be safely discharged home. A major strength of our study was the inclusion of a large number of consecutive end-stage liver disease patients with SPSS (n 5 75) undergoing LT over a short period of time (6 years) at a single center with complete data and managed according to a prospective algorithm.
We used a composite end point method to determine the effect of ligation versus nonligation of the shunt on short-term outcomes to increase statistical efficiency (33) and to avoid the issue of multiplicity and competing risk. On the other hand, the main disadvantages associated with the use of composite end points could not be avoided: all components were treated equally important, and in time-to-event analyses, the first event considered may not be the most important one. However, the variables (multiple end points) of our composite end point were chosen according to previous reports of relevant end points in this setting. In our study, on univariate analysis, post-LT encephalopathy and PVT were significantly different in the 2 groups. Incidence of PNF and PDF were, however, not different in the 2 groups.
Our study had some limitations including the intrinsic bias because of its retrospective nature. A randomized study comparing SPSS ligation versus nonligation could answer the question of benefit with a sufficient level of evidence. However, beyond practical reasons, such a study might be unethical taking into account the present results. The ligation of the left renal vein showed no renal complications in the SPSS group although this is an area of debate. Most authors agree that it is safe, but the data presented are likely underpowered regarding this point. A longer cold ischemia time in the nonligated shunt group might have an influence on the outcome in this group. The overall Model for End-Stage Liver Disease (MELD) scores at time of transplants were equivalent in the populations albeit quite low. In other centers, median MELD score at transplant can be higher than 35, which raises a question as to what is the right answer in these patients. Increased blood loss, vasopressor support, and continuous renal replacement are all factors intraoperatively for these high-MELD patients who may inhibit surgeons from trying to go after these shunts because it can prolong an operation and increase potential for bleeding. Although it is possible, the patient population should be taken into account in the surgical management of SPSS. As used to guide modulation of the portal flow and obviate overperfusion in partial LT, (34) intraoperative portal vein flow/pressure and hepatic venous pressure gradient measurements could be used to decide on shunt ligation to obviate portal hypoperfusion. In the setting of SPSS, according to the scarce data available, (35) (36) (37) SPSS ligation is advised when portal flow is <1 L/minute.
The results of the present study should be interpreted with some caution. Our data do not support that all SPSS should be ligated after portal reconstruction regardless of what is found subjectively intraoperatively after "test clamp." We advocate 2 situations in which SPSS should not be ligated routinely:
1. In case of small size graft (split-liver living donor graft or small whole liver graft with low graft-tobody weight ratio), SPSS ligation may have detrimental effects and cause subsequent increased portal inflow to the graft, portal hyperperfusion, and graft dysfunction. (38) 2. If control and ligation of SPSS is difficult from a technical point of view (massive bleeding, many collateral veins), we think it may be useless to try to control and ligate the SPSS in such cases.
Some authors have also suggested the pre-LT embolization of SPSS (39) or postoperative shunt embolization if needed (2) to obviate the challenging control of the shunt during LT in the presence of portal hypertension. On the other hand, in the case of persistence or recurrence of hepatic encephalopathy presumably related to persistent or recanalization of previous ligated SPSS, the post-LT embolization of dominant large SPSS may be an interesting option. (39) In conclusion, the present clinical investigation adds to a growing body of literature on the management of SPSS in LT. Surgical SPSS ligation appears to be more efficient, not only for adequately revascularizing the graft, but also for better short-term and longterm outcomes. In addition, pretransplant portal vein patency and the presence of SPSS need to be carefully evaluated to anticipate any intraoperative portal revascularization difficulties.
